GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLLS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Friday for Cellectis S.A.
(Updated on Apr 19, 2024)

Sell candidate since Apr 12, 2024 Loss -5.20% PDF

The Cellectis S.A. stock price gained 3.24% on the last trading day (Friday, 19th Apr 2024), rising from $2.47 to $2.55. During the last trading day the stock fluctuated 2.78% from a day low at $2.51 to a day high of $2.58. The price has risen in 6 of the last 10 days but is still down by -4.85% for this period. Volume fell on the last day by -3 thousand shares and in total, 12 thousand shares were bought and sold for approximately $29.94 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.16% during the next 3 months and, with a 90% probability hold a price between $1.95 and $2.40 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CLLS Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 3.66%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cellectis S.A. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.58 and $2.59. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Cellectis S.A. stock

Cellectis S.A. finds support from accumulated volume at $2.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0699 between high and low, or 2.78%. For the last week the stock has had daily average volatility of 6.59%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLLS) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Cellectis S.A. to open at $2.55, and during the day (based on 14 day Average True Range), to move between $2.39 and $2.71, which gives a possible trading interval of +/-$0.164 (+/-6.45%) up or down from last closing price. If Cellectis S.A. takes out the full calculated possible swing range there will be an estimated 12.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.54 (0.39%) than the resistance at $2.69 (5.49%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cellectis S.A. stock A Buy?

Cellectis S.A. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.675 Sell Candidate Unchanged

Predicted Opening Price for Cellectis S.A. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$2.55 ( 0.129%) $2.55

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CLLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.62 2.61 %
R2 2.59 1.56 %
R1 2.57 0.92 %
Current price: 2.55
Support S1 2.52 -1.18 %
S2 2.50 -1.82 %
S3 2.48 -2.87 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.79 9.41 %
R2 2.72 6.67 %
R1 2.69 5.49 %
Current price 2.55
Support S1 2.54 -0.392%
S2 2.49 -2.35%
S3 2.48 -2.75%

FAQ

What is the symbol for Cellectis S.A. Stock and on which exchange is it traded?
The symbol for Cellectis S.A. is CLLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cellectis S.A. Stock?
Cellectis S.A. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Cellectis S.A. Stock?
Cellectis S.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cellectis S.A. Stock.

What's the current price of Cellectis S.A. Stock?
As of the end of day on the 2024-04-19, the price of an Cellectis S.A. (CLLS) share was $2.55.

What is the 52-week high and low for Cellectis S.A. Stock?
The 52-week high for Cellectis S.A. Stock is $3.77 and the 52-week low is $0.96.

What is the market capitalization of Cellectis S.A. Stock?
As of the 2024-04-19, the market capitalization of Cellectis S.A. is 182.966M.

When is the next earnings date for Cellectis S.A.?
The upcoming earnings date for Cellectis S.A. is May 02, 2024.
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT